Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 October 2022 | Story Anthony Mthembu | Photo Kaleidoscope
Tobias van den Bergh
Tobias van den Bergh, President of the Southern African Association for Counselling and Development in Higher Education (SAACHDE)

Tobias van den Bergh, Counselling Psychologist at the University of the Free State, has been appointed as the President of the Southern African Association for Counselling and Development in Higher Education (SAACDHE).  The appointment became official at the annual SAACDHE conference, which took place in Pretoria from 12 to 14 September 2022. As such, van den Bergh perceives this appointment as an opportunity: “To be part of a creative process that tackles the challenges faced in higher education and knowing the difficulty that students and my colleagues across the country are struggling with, accepting this appointment felt right.”

The role of SAACDHE

“The organisation represents members of several higher education counselling and career development centres from the SADC region. The organisation’s mission is to promote, guide, and advance best practices in centres at institutions of higher education,” explained Van den Bergh. Through this representation and assistance, members are able to provide quality support to the students they serve. SAACDHE members include mental health professionals, social workers, HIV/AIDS counsellors, researchers, and career development specialists from more than 15 higher education institutions in South Africa and Botswana. Furthermore, Van den Bergh asserts that, “SAACDHE represents its members through lobbying for increased institutional support, the promotion of scholarly, ethical, and best practices, and the training and development of professionals.”

Van den Bergh as President of the organisation

 As the newly elected President of the organisation, there are several challenges that Van den Bergh believes require the immediate attention of SAACDHE.  For instance, he maintains that student populations and the mental health challenges they face have grown at a substantial rate over the past few decades. However, the staff capacity in counselling and career development centres has not increased commensurately. As such, the challenge in this regard is that the need for mental health interventions continues to grow, but the capacity is not sufficient to deal with those challenges and to fill the gap in public mental health services. To address this challenge, he indicates that “the organisation is striving to innovate counselling centres, and to find ways to work smarter and be preventative where possible”.

In addition, Van den Bergh is adamant about ensuring that the organisation continues to be innovative in the way mental health services are provided to students, and to create practices that are culturally and contextually relevant. However, his long-term vision for the organisation is, “to continue serving as a training, development, and practice-based organisation, so that we can equip members with support and knowledge that will help them to continue helping students in a smarter and better way”.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept